Literature DB >> 12417647

Ciliary neurotrophic factor (CNTF) enhances myelin formation: a novel role for CNTF and CNTF-related molecules.

Bruno Stankoff1, Marie-Stéphane Aigrot, Frédéric Noël, Aurélie Wattilliaux, Bernard Zalc, Catherine Lubetzki.   

Abstract

In multiple sclerosis, myelin repair is generally insufficient despite the relative survival of oligodendrocytes within the plaques and the recruitment of oligodendrocyte precursors. Promoting remyelination appears to be a crucial therapeutic challenge. Using a newly developed enzymatic index of myelination, we screened different neurotrophic factors for their ability to enhance myelination. Neurotrophins [NGF, neurotrophin-3 (NT-3), NT-4/5, BDNF], glial cell line-derived neurotrophic factor (GDNF)-related factors (GDNF, neurturin), and growth factors such as PDGF-AA, FGF-2, and insulin did not increase myelinogenesis. In contrast, among factors belonging to the CNTF family, CNTF, leukemia inhibitory factor, cardiotrophin-1, and oncostatin M induced a strong promyelinating effect. We provide evidence that CNTF acts on oligodendrocytes by favoring their final maturation, and that this effect is mediated through the 130 kDa glycoprotein receptor common to the CNTF family and transduced through the Janus kinase pathway. Our results demonstrate a novel role for neurotrophic factors of the CNTF family and raise the possibility that these factors might be of therapeutic interest to promote remyelination in multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12417647      PMCID: PMC6758026     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  91 in total

1.  Mechanisms Involved in the Remyelinating Effect of Sildenafil.

Authors:  Daniela Díaz-Lucena; María Gutierrez-Mecinas; Beatriz Moreno; José Lupicinio Martínez-Sánchez; Paula Pifarré; Agustina García
Journal:  J Neuroimmune Pharmacol       Date:  2017-08-03       Impact factor: 4.147

Review 2.  Anterograde transport of neurotrophic factors: possible therapeutic implications.

Authors:  Matteo Caleo; Maria Cristina Cenni
Journal:  Mol Neurobiol       Date:  2004-04       Impact factor: 5.590

Review 3.  Purinergic trophic signalling in glial cells: functional effects and modulation of cell proliferation, differentiation, and death.

Authors:  Davide Lecca; Stefania Ceruti; Marta Fumagalli; Maria P Abbracchio
Journal:  Purinergic Signal       Date:  2012-04-12       Impact factor: 3.765

Review 4.  Intramuscular interferon-beta-1a: in patients at high risk of developing clinically definite multiple sclerosis.

Authors:  M Asif A Siddiqui; Keri Wellington
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 5.  Polarity development in oligodendrocytes: sorting and trafficking of myelin components.

Authors:  Olaf Maier; Dick Hoekstra; Wia Baron
Journal:  J Mol Neurosci       Date:  2008-01-03       Impact factor: 3.444

6.  CNTF promotes the survival and differentiation of adult spinal cord-derived oligodendrocyte precursor cells in vitro but fails to promote remyelination in vivo.

Authors:  Jason F Talbott; Qilin Cao; James Bertram; Michael Nkansah; Richard L Benton; Erin Lavik; Scott R Whittemore
Journal:  Exp Neurol       Date:  2006-12-20       Impact factor: 5.330

7.  Up-regulation of ciliary neurotrophic factor in astrocytes by aspirin: implications for remyelination in multiple sclerosis.

Authors:  Khushbu K Modi; Michael Sendtner; Kalipada Pahan
Journal:  J Biol Chem       Date:  2013-05-07       Impact factor: 5.157

8.  Continued administration of ciliary neurotrophic factor protects mice from inflammatory pathology in experimental autoimmune encephalomyelitis.

Authors:  Tanja Kuhlmann; Leah Remington; Isabelle Cognet; Lyne Bourbonniere; Simone Zehntner; Florence Guilhot; Alexandra Herman; Angélique Guay-Giroux; Jack P Antel; Trevor Owens; Jean-François Gauchat
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

Review 9.  Neurotrophic factors in neurodegenerative disorders : potential for therapy.

Authors:  Fabio Fumagalli; Raffaella Molteni; Francesca Calabrese; Paola Francesca Maj; Giorgio Racagni; Marco Andrea Riva
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 10.  Toll-like receptors in neurodegeneration.

Authors:  Eitan Okun; Kathleen J Griffioen; Justin D Lathia; Sung-Chun Tang; Mark P Mattson; Thiruma V Arumugam
Journal:  Brain Res Rev       Date:  2008-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.